GMED vs HAE: stock comparison and AI forecast
Globus Medical Inc (GMED) and Haemonetics Corp (HAE) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
GMED Globus Medical Inc
- Market Cap
- $11.69B
- P/E Ratio
- 24.7x
- Size
- large-cap
- AI Forecast
HAE Haemonetics Corp
- Market Cap
- $5.80B
- P/E Ratio
- 61.6x
- Size
- mid-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- GMED is 2.0 times larger than HAE by market capitalization ($11.69B against $5.80B).
- GMED trades at 24.7 times trailing earnings, HAE at 61.5 times.
- HAE carries 1.83 times debt per unit of equity, against 0.11 times for GMED.
- Both companies share the SEC industry classification Surgical & Medical Instruments & Apparatus.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | GMED | HAE |
|---|---|---|
| Market Cap | $11.69B | $5.80B |
| P/E Ratio | 24.67x | 61.55x |
| P/B Ratio | 5.89x | 6.93x |
| EPS | $3.53 | $2.07 |
| Book Value/Share | $14.79 | $18.40 |
| Revenue/Share | $23.42 | $29.72 |
| FCF/Share | $5.63 | $6.40 |
Profitability & Margins
| Metric | GMED | HAE |
|---|---|---|
| ROIC | – | 7.6% |
| Gross Margin | 68.5% | 59.0% |
| Operating Margin | 54.8% | 11.7% |
| EBT Margin | 56.6% | 9.5% |
| Tax Rate | 18.9% | 26.2% |
Financial Health
| Metric | GMED | HAE |
|---|---|---|
| Current Ratio | 4.62x | 3.08x |
| Quick Ratio | 2.93x | 1.91x |
| D/E Ratio | 0.11x | 1.83x |
| Financial Leverage | – | 2.83x |
| Interest Coverage | 94.4x | – |
| Working Capital | $1.74B | $548M |
Cash Flow
| Metric | GMED | HAE |
|---|---|---|
| Operating Cash Flow | $910M | $328M |
| Free Cash Flow | $756M | $291M |
| Capital Spending | -$155M | -$37M |
| OCF Growth YoY | 36.0% | 44.9% |
| FCF Growth YoY | 43.3% | 13.7% |
| FCF/Sales | 24.0% | 21.5% |
| CapEx/Sales | 4.9% | 2.7% |
Operational Efficiency
| Metric | GMED | HAE |
|---|---|---|
| Asset Turnover | – | 0.57x |
| Receivables Turnover | 4.5x | 6.3x |
| Inventory Turnover | 1.2x | 1.8x |
| Fixed Assets Turnover | 5.9x | 4.5x |
| Days Sales Outstanding | 80 days | 58 days |
| Days Inventory | 299 days | 202 days |
| Payables Period | 39 days | 37 days |
| Cash Conversion Cycle | 340 days | 223 days |
Income Statement
| Metric | GMED | HAE |
|---|---|---|
| Total Revenue | $3.14B | $1.35B |
| Operating Income | $640M | $160M |
| R&D Expense | $147M | $60M |
| SG&A Expense | $1.22B | $451M |
| Cost of Goods Sold | $989M | $554M |
Dividend & Shareholder Information
| Metric | GMED | HAE |
|---|---|---|
| Shares Outstanding | 134M | 46M |
| EPS Growth | 75.6% | -36.7% |
GMED vs HAE: stock comparison and AI forecast
Which is bigger, GMED or HAE?
GMED is 2.0 times larger than HAE by market capitalization ($11.69B against $5.80B).
Which is cheaper on earnings, GMED or HAE?
GMED trades at 24.7 times trailing earnings, HAE at 61.5 times.
Which one does Intratio's AI model rank higher, GMED or HAE?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.